Abstract:2, 4‐Diamino‐6‐hydroxypyrimidine (DHP) is a chemical compound with significant relevance in various fields of science and medicine with distinctive chemical properties have extensive applications in pharmaceuticals, coordination chemistry, and the synthesis of bioactive compounds. In medicinal chemistry the production of NO from t_‐arginine and molecular oxygen in cytokine‐activated cells. But low bioavailability of the former one makes a boundary to boost its applications. The goal of the present research has to found the way to manipulate the bioavailability of the biologically significant DHP molecule. Here we explore the Molecular encapsulation is a significant tactic to enhance the bioavailability of some medications while maintaining their therapeutic effect with Cyclodextrins (CDs). This research aims to develop the inclusion complex of 2, 4‐diamino‐6‐hydroxypyrimidine (DHP) with β‐cyclodextrin (β‐CD) using an inclusion process, and to investigate the effect of inclusion on the photo stability and bioactivity of DHP. The formation of DHP‐β‐CD inclusion complex has been examined by means of physicochemical as well as spectroscopic techniques (1H NMR, FT‐IR, PXRD and SEM) suggesting the successful inclusion of the DHP molecule into the β‐CD cavity. The 1 : 1 stoichiometry of the inclusion complex was validated through Job's plot. β‐CD displayed a fairly strong affinity (Ka =889.67 M−1) for DHP, indicating that the binding process is thermodynamically feasible. A molecular docking study speculated the most preferred orientation of DHP molecule within the binding pocket of β‐CD cavity. The photostability of DHP was found to improve on complexation with β‐CD. In vitro antibacterial activity test demonstrated that the DHP‐β‐CD inclusion complex displayed better activity than pure DHP. DHP‐β‐CD inclusion complex (IC50 =240.04 μM) also exhibited relatively significant in vitro cytotoxic activity than pure DHP towards the human kidney cancer cell line (ACHN). These results reveals that the inclusion of DHP using β‐CD could lead to stabilization of DHP and efficient display of its bioactivity.

Inclusion Complexes of Nateglinide with HP–β–CD and L-Arginine for Solubility and Dissolution Enhancement: Preparation, Characterization, and Molecular Docking Study

Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin

Enhanced solubility and oral bioavailability of niclosamide- sulfobutylether-β-cyclodextrin sodium inclusion complexes: An approach to improve its repurposing potential

Gliclazide in Binary and Ternary Systems Improves Physicochemical Properties, Bioactivity, and Antioxidant Activity

Optimizing Nateglinide Liquisolid Compacts: Achieving Formulation Excellence Through the Quality by Design Approach

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement

ENHANCED SOLUBILITY AND DISSOLUTION BY SURFACE-MODIFIED SOLID DISPERSION OF ALECTINIB HYDROCHLORIDE

Inclusion Complex of Chrysin with Hydroxypropyl-β-cyclodextrin (HP-β-CD) Preparation, Characterization, and Dissolution Study

Probing Host‐Guest Inclusion Complex of DHP with β‐CD in Augmenting Bioavailability to Boost Biochemical Applications Optimized by Physicochemical and Molecular Docking

Effect of Cyclodextrin Complex Formation on Solubility Changes of Each Drug Due to Intermolecular Interactions between Acidic NSAIDs and Basic H2 Blockers

Inclusion complexes of nabumetone with β-cyclodextrins: Spectroscopic, spectrometric and calorimetric studies in solution

Preparation of Gliclazide-Hydroxypropyl-β-cyclodextrin Inclusion Complexes

Preparation and characterization of amoxapine- and naringin-loaded solid lipid nanoparticles: drug-release and molecular-docking studies

Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation

Solubility and Dissolution Enhancement of Candesartan Cilexetil by Complexation with Cyclodextrin

Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability

Co-processing of nateglinide with meglumine for enhanced dissolution rate: in vitro and in vivo evaluation

Molecular Interaction and Solubilization Efficiency of Neohesperidin in Ternary Systems with Hydroxypropyl-β-cyclodextrin and Meglumine

Simultaneously Inhibiting P-gp Efflux and Drug Recrystallization Enhanced the Oral Bioavailability of Nintedanib